Use in adolescents and adults, including the elderly: Tobradex Ophthalmic Suspension: One or two drops instilled into the conjunctival sac(s) every 4 to 6 hours. During the initial 24 to 48 hours, the dose may be increased to one or two drops every two hours. Frequency should be decreased gradually as warranted by the improvement in clinical signs. Care should be taken not to discontinue therapy prematurely.
Tobradex Ophthalmic Ointment: Apply a small amount (approximately 1⁄2 inch ribbon) into the conjunctival sac(s) up to 3 or 4 times daily.
May be used adjunctively with drops at bedtime.
Use in children: Safety and efficacy in children have not been established.
Use in patients with hepatic or renal impairment: TOBRADEX has not been studied in these patient populations.
Method of administration: For ocular use only.
After cap is removed, if tamper evident snap collar is loose, remove before using product.
The bottle must be well shaken before use.
To prevent contamination of the dropper tip and suspension, care must be taken not to touch the eyelids, surrounding areas or other surfaces with the dropper tip of the bottle [Tobradex Ophthalmic Suspension].
Do not let the tip of the tube touch the eye [Tobradex Ophthalmic Ointment].
Gently closing the eyelid and nasolacrimal occlusion after instillation is recommended. This may reduce the systemic absorption of medicinal products administered via the ocular route and result in a decrease in systemic side effects.
In case of concomitant therapy with other topical ocular medicinal products, an interval of 5 minutes should be allowed between successive applications. Eye ointments should be administered last.